LifeSci Venture Partners

LifeSci Venture Partners

LifeSci Venture Partners

GeekWire

Athira Pharma raises $204M in IPO, reaching ‘big milestone’ in fight against Alzheimer’s and other diseases

GeekWire

Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020

GeekWire

Seattle biotech Athira Pharma sets terms for IPO, aims to raise up to $170M

$30,000,000 Venture capital (Series C)
FinSMEs

Orasis Raises $30M in Series C Funding

$36,000,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

Erasca Completes $36M Extension of Series B Financing

GeekWire

Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs

$85,000,000 Venture capital (Series B)
MedCity News , GeekWire

Athira Pharma raises $85 million in Series B round

FinSMEs

Athira Pharma Closes $85M Series B Financing

Xconomy

Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More

$200,000,000 Venture capital (Series B)
thetechstartups , Pulse 2.0

Biotech startup Erasca raises $200 million Series B funding to fight cancer

DealStreetAsia , Crunchbase News , FinSMEs , +1

Singapore’s EDBI joins US oncology startup Erasca’s $200m Series B round

FinSMEs

Biolinq Expands Series A Financing With $4.75M Investment

$4,750,000 Venture capital
Xconomy

Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch

$22,000,000 Venture capital (Series A)
FinSMEs

Erasca Raises Series A Extension; Round Totals $64M

$42,000,000 Venture capital (Series A)
StartupWorld

Erasca Launches With $42 Million To Support Erasing Cancer

$70,000,000 Venture capital (Series B)
PE HUB , FinSMEs

Akero Therapeutics locks in $70 mln Series B

$128,400,000 IPO
PE HUB

VC-backed Allakos goes public

Stock markets Funding Costs
$65,000,000 Venture capital (Series A)
FinSMEs

Akero Therapeutics Closes $65M Series A Financing

Funding Health Science
$10,000,000 Venture capital (Series A)
PE HUB

Digital health company Biolinq takes in $10 mln